Matthew Deneke, MD in Little Rock, AR - Medicare Gastroenterology

Matthew Deneke, MD is a medicare enrolled "Internal Medicine - Gastroenterology" physician in Little Rock, Arkansas. He went to University Of Arkansas College Of Medicine and graduated in 2002 and has 22 years of diverse experience with area of expertise as Gastroenterology. He is a member of the group practice University Of Arkansas and his current practice location is 4301 W Markham St # 783, Little Rock, Arkansas. You can reach out to his office (for appointments etc.) via phone at (501) 686-8000.

Matthew Deneke is licensed to practice in Minnesota (license number 56852) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1689764151.

Contact Information

	Matthew Deneke, MD
	4301 W Markham St # 783, Little Rock, AR 72205
	(501) 686-8000
	(501) 526-4596

Physician's Profile

Full Name	Matthew Deneke
Gender	Male
Speciality	Gastroenterology
Experience	22 Years
Location	4301 W Markham St # 783, Little Rock, Arkansas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Matthew Deneke attended and graduated from University Of Arkansas College Of Medicine in 2002

NPI Data:

NPI Number: 1689764151
Provider Enumeration Date: 10/13/2006
Last Update Date: 09/26/2018

Medicare PECOS Information:

PECOS PAC ID: 1254360365
Enrollment ID: I20050809000911

Medical Identifiers

Medical identifiers for Matthew Deneke such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1689764151	NPI	-	NPPES
157947001	Medicaid	AR
05060013900	Other	AR	QUALCHOICE
5N259	Other	AR	BCBS
P00295353	Other	AR	RAILROAD MEDICARE1

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RG0100X	Internal Medicine - Gastroenterology	107008 (Minnesota)	Secondary
207RG0100X	Internal Medicine - Gastroenterology	56852 (Minnesota)	Primary
207R00000X	Internal Medicine	E-4436 (Arkansas)	Secondary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Uams Medical Center	Little rock, AR	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
University Of Arkansas	4082528955	1121

News Archive

States' woes spur Medicaid drop-out talk

This story, a collaboration between Kaiser Health News' Marilyn Werber Serafini, the Kaiser Family Foundation's Robin Toner Distinguished Fellow, and the Texas Tribune's Emily Ramshaw, reports on Medicaid developments: "A week after newly emboldened Republicans in the Texas Legislature floated a radical cost-saving proposal — opting out of the federal Medicaid program — health care experts, economists and think tanks are trying to determine just how serious they are, and if it would even be possible" (Ramshaw and Serafini, 11/12).

Ventrus prices initial public offering at $6.00 per share

Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced the pricing of its initial public offering of 2,900,000 shares at $6.00 per share. The shares are expected to begin trading tomorrow, December 17, 2010 on the Nasdaq Capital Market under the symbol "VTUS". In addition, Ventrus has granted the underwriters a 45-day option to purchase up to an additional 435,000 shares to cover over-allotments, if any.

Journal Homeopathy highlights a remarkable range of findings on homeopathic treatments

The journal Homeopathy (http://www.elsevier.com/locate/homp) has published a two part special issue focusing on biological models of homeopathy. The special issue highlights experiments on homeopathic treatments in biological models, ranging from whole animals and plants to cell cultures and enzymes, showing a remarkable range of findings.

Study: Ipilimumab with VEGF inhibitors may be potential option for melanoma patients

Among patients with advanced melanoma, presence of higher levels of the protein vascular endothelial growth factor (VEGF) in blood was associated with poor response to treatment with the immunotherapy ipilimumab, according to a study published in Cancer Immunology Research, a journal of the American Association for Cancer Research.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Matthew Deneke allows following entities to bill medicare on his behalf.

Entity Name	University Of Arkansas For Medical Sciences
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706

News Archive

States' woes spur Medicaid drop-out talk

Ventrus prices initial public offering at $6.00 per share

Journal Homeopathy highlights a remarkable range of findings on homeopathic treatments

Study: Ipilimumab with VEGF inhibitors may be potential option for melanoma patients

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Matthew Deneke is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Matthew Deneke, MD 4301 W Markham St # 783, Little Rock, AR 72205-7199 Ph: (501) 686-8000	Matthew Deneke, MD 4301 W Markham St # 783, Little Rock, AR 72205 Ph: (501) 686-8000

News Archive

States' woes spur Medicaid drop-out talk

Ventrus prices initial public offering at $6.00 per share

Journal Homeopathy highlights a remarkable range of findings on homeopathic treatments

Study: Ipilimumab with VEGF inhibitors may be potential option for melanoma patients

Internal Medicine Doctors in Little Rock, AR

Lonnie E Harrison, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7 Shackleford West Blvd, Little Rock, AR 72211 Phone: 501-664-5860 Fax: 501-664-0889
Muthu Veera Kumaran, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 556, Little Rock, AR 72205 Phone: 501-686-6033 Fax: 501-686-8932
Armaghan Yunis Soomro, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7282 Fax: 201-277-9765
Tanvi Harishbhai Patel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 508, Little Rock, AR 72205 Phone: 501-686-7105 Fax: 501-526-5906
Gaurav Dhar, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000
Anthony R Giglia Iii, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5800 W 10th St, Ste 610 Freeway Medical Center, Little Rock, AR 72204 Phone: 501-661-9393 Fax: 501-663-4795
Brian Bean, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: #2 St Vincent Circle, Little Rock, AR 72205 Phone: 501-552-3592 Fax: 501-552-4129

Matthew Deneke, MD - Medicare Gastroenterology in Little Rock, AR

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

States' woes spur Medicaid drop-out talk

Ventrus prices initial public offering at $6.00 per share

Journal Homeopathy highlights a remarkable range of findings on homeopathic treatments

Study: Ipilimumab with VEGF inhibitors may be potential option for melanoma patients

Medicare Reassignments

States' woes spur Medicaid drop-out talk

Ventrus prices initial public offering at $6.00 per share

Journal Homeopathy highlights a remarkable range of findings on homeopathic treatments

Study: Ipilimumab with VEGF inhibitors may be potential option for melanoma patients

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

States' woes spur Medicaid drop-out talk

Ventrus prices initial public offering at $6.00 per share

Journal Homeopathy highlights a remarkable range of findings on homeopathic treatments

Study: Ipilimumab with VEGF inhibitors may be potential option for melanoma patients

Internal Medicine Doctors in Little Rock, AR